Scarica l'app Stockscreener
9.28
1.69%
-0.16
Precedente Chiudi:
$9.44
Aprire:
$9.39
Volume 24 ore:
177.81K
Relative Volume:
0.84
Capitalizzazione di mercato:
$459.09M
Reddito:
$62.02M
Utile/perdita netta:
$-45.65M
Rapporto P/E:
-10.09
EPS:
-0.92
Flusso di cassa netto:
$-9.60M
1 W Prestazione:
-4.43%
1M Prestazione:
-2.11%
6M Prestazione:
+14.00%
1 anno Prestazione:
+5.45%
Intervallo 1D:
$9.06
$9.39
Intervallo di 1 settimana:
$9.06
$9.91
Portata 52W:
$7.44
$10.90
Theravance Biopharma Inc Stock (TBPH) Company Profile
Nome
Theravance Biopharma Inc
Settore
Industria
Telefono
650-808-6000
Indirizzo
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Confronta TBPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
9.28 | 459.09M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | Iniziato | BTIG Research | Buy |
| 2024-01-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2021-11-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | JP Morgan | Overweight → Underweight |
| 2021-08-25 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-10-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | Iniziato | JP Morgan | Overweight |
| 2020-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-05-13 | Iniziato | Cowen | Outperform |
| 2020-01-08 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-06 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-29 | Ripresa | Piper Jaffray | Overweight |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-06-16 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-12-21 | Iniziato | Needham | Buy |
| 2016-11-03 | Iniziato | Piper Jaffray | Overweight |
| 2016-10-12 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | Iniziato | Guggenheim | Buy |
| 2016-06-20 | Reiterato | Leerink Partners | Outperform |
| 2016-05-12 | Iniziato | Leerink Partners | Outperform |
| 2016-05-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
Mostra tutto
Theravance Biopharma Inc Borsa (TBPH) Ultime notizie
Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive - Seeking Alpha
Rhumbline Advisers Sells 3,110 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Theravance Biopharma Inc to Host Earnings Call - ACCESS Newswire
Theravance Biopharma, Inc. to Host Earnings Call - ACCESS Newswire
What is Zacks Research’s Forecast for TBPH Q1 Earnings? - Defense World
Where are the Opportunities in (TBPH) - Stock Traders Daily
Equities Analysts Issue Forecasts for TBPH FY2028 Earnings - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Analysts Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75 - MarketBeat
HC Wainwright Reiterates Buy Rating for Theravance Biopharma (NASDAQ:TBPH) - MarketBeat
Theravance Biopharma Reports Strong Q4 2024 Earnings - TipRanks
Investor Network: Theravance Biopharma Inc to Host Earnings Call - ACCESS Newswire
Research Analysts Issue Forecasts for TBPH FY2024 Earnings - Defense World
Theravance Biopharma (NASDAQ:TBPH) Releases Earnings Results, Misses Estimates By $0.26 EPS - MarketBeat
Theravance's Q4 Loss In Line With Estimates, Sales Beat - Yahoo Finance
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2024 Earnings Call Transcript - Insider Monkey
FY2024 Earnings Forecast for TBPH Issued By HC Wainwright - MarketBeat
HC Wainwright Reiterates “Buy” Rating for Theravance Biopharma (NASDAQ:TBPH) - Defense World
Theravance Biopharma Inc (TBPH) Q4 2024 Earnings Call Highlights: Record Sales and Strategic ... By GuruFocus - Investing.com Canada
Theravance Biopharma Inc (TBPH) Q4 2024 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
What is HC Wainwright’s Estimate for TBPH FY2028 Earnings? - Defense World
Theravance Biopharma (TBPH) Reports Q4 Loss, Tops Revenue Estimates - MSN
Theravance Biopharma Reports Record 2024 Financial Results - TipRanks
Theravance Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results - PR Newswire
Theravance Biopharma Inc Reports Q4 2024 Earnings: YUPELRI Sales - GuruFocus.com
Earnings To Watch: Theravance Biopharma Inc (TBPH) Reports Q4 20 - GuruFocus.com
Earnings To Watch: Theravance Biopharma Inc (TBPH) Reports Q4 2024 Result - Yahoo Finance
Theravance Biopharma: Strategic Milestones and Revenue Forecasts Justify Buy Rating - TipRanks
Theravance Biopharma Inc expected to post a loss of 21 cents a shareEarnings Preview - TradingView
Theravance Biopharma (TBPH) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Inside Access: Theravance Biopharma's Strategic Update at Elite Healthcare Conference - StockTitan
(TBPH) Technical Data - Stock Traders Daily
Theravance biopharma SVP Rhonda Farnum sells $36,000 in shares - MSN
Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation - Yahoo Finance
Theravance Biopharma Earnings: Key Financial Results Coming February 26What's Next for TBPH? - StockTitan
TBPHTheravance Biopharma, Inc. Latest Stock News & Market Updates - StockTitan
Theravance Biopharma to Participate in an Upcoming Investor Conference - PR Newswire
Exclusive: Theravance Biopharma Takes Center Stage at Major Healthcare Conference - StockTitan
Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock? - MSN
Theravance Biopharma (NASDAQ:TBPH) Hits New 12-Month High – Should You Buy? - Defense World
Theravance Biopharma (NASDAQ:TBPH) Trading Up 8.8%Still a Buy? - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Reaches New 12-Month HighHere's Why - MarketBeat
Theravance Biopharma stock hits 52-week high at $10.47 - MSN
Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Rhonda Farnum Sells 4,000 Shares - MarketBeat
Theravance Biopharma stock hits 52-week high at $10.47 By Investing.com - Investing.com South Africa
Theravance Biopharma (NASDAQ:TBPH) shareholders are up 15% this past week, but still in the red over the last five years - Simply Wall St
Theravance Biopharma Inc Azioni (TBPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.39%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):